The combination of trifluridine/tipiracil and oxaliplatin induces immunogenic cell death in microsatellite stable colorectal cancer von Ghiringhelli, F, Limagne, E, Thibaudin, M, Nuttin, L, Spill, A, Derangere, V, Cattan, V, Peranzoni, E, Amellal, N

Volltext

Deep learning for colon cancer histopathological images analysis von Ben Hamida, A., Devanne, M., Weber, J., Truntzer, C., Derangère, V., Ghiringhelli, F., Forestier, G., Wemmert, C.

Volltext

Liver X receptor β activation induces pyroptosis of human and murine colon cancer cells von Derangère, V, Chevriaux, A, Courtaut, F, Bruchard, M, Berger, H, Chalmin, F, Causse, S Z, Limagne, E, Végran, F, Ladoire, S, Simon, B, Boireau, W, Hichami, A, Apetoh, L, Mignot, G, Ghiringhelli, F, Rébé, C

Volltext

Inhibition of colon cancer growth by docosahexaenoic acid involves autocrine production of TNFα von Fluckiger, A, Dumont, A, Derangère, V, Rébé, C, de Rosny, C, Causse, S, Thomas, C, Apetoh, L, Hichami, A, Ghiringhelli, F, Rialland, M

Volltext

Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR) von Basile, D., Broudin, C., Emile, J.F., Falcoz, A., Pagès, F., Mineur, L., Bennouna, J., Louvet, C., Artru, P., Fratte, S., Ghiringhelli, F., André, T., Derangère, V., Vernerey, D., Taieb, J., Svrcek, M.

Volltext

Weakly Supervised Learning using Attention gates for colon cancer histopathological image segmentation von Ben Hamida, A., Devanne, M., Weber, J., Truntzer, C., Derangère, V., Ghiringhelli, F., Forestier, G., Wemmert, C.

Volltext

78P Prognostic value of thyroid transcription factor-1 expression in lung adenocarcinoma in patients treated with anti PD-1/PD-L1 von Galland, L., Lecuelle, J., Lepage, A.L., Bibeau, F., Derangere, V., Truntzer, C., Ghiringhelli, F.

Volltext

Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression von Chalmin, Fanny, Mignot, Grégoire, Bruchard, Mélanie, Chevriaux, Angélique, Végran, Frédérique, Hichami, Aziz, Ladoire, Sylvain, Derangère, Valentin, Vincent, Julie, Masson, David, Robson, Simon C., Eberl, Gerard, Pallandre, Jean René, Borg, Christophe, Ryffel, Bernhard, Apetoh, Lionel, Rébé, Cédric, Ghiringhelli, Francois

Volltext

165P Pathologic and immunohistochemical prognostic score in residual triple-negative breast cancer after neoadjuvant chemotherapy von Ilie, S.M., Arnould, L., Briot, N., Desmoulins, I., Hennequin, A., Kaderbhai, C., Bertaut, A., Coutant, C., Causeret, S., Loustalot, C., Ilie, A., Derangere, V., Ladoire, S.

Volltext

164P Effect of ELOVL5 expression on breast cancer development von Kieu, T.L.V., Pierre, L., Perrey, S., Derangere, V., Truntzer, C., Jalil, A., Dumont, A., Masson, D., Thomas, C., Ghiringhelli, F., Rialland, M.

Volltext

PD-L1 and IL17 expression in tumor infiltrating lymphocytes are opposite prognostic factors in glioblastoma von Bronsart, E., Derangere, V., Boone, M., Chauffert, B., Ghiringhelli, F.

Volltext

EP1.01-25 An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients von Richard, C., Fumet, J., Chevrier, S., Derangere, V., Boidot, R., Truntzer, C., Ghiringhelli, F.

Volltext

521 Circulating PD-L1-exosomes to monitor tumor response in melanoma patients von Nardin, C., Cordonnier, M., Chanteloup, G., Derangere, V., Algros, M., Arnould, L., Garrido, C., Aubin, F., Gobbo, J.

Volltext

PD-L1 and IL17 expression in tumor infiltrating lymphocytes are opposite prognostic factors in glioblastoma von Bronsart, E., Derangere, V., Boone, Mathieu, Chauffert, Bruno, Ghiringhelli, F.

Volltext

Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients von Nambot, S., Sawka, C., Bertolone, G., Cosset, E., Goussot, V., Derangère, V., Boidot, R., Baurand, A., Robert, M., Coutant, C., Loustalot, C., Thauvin-Robinet, C., Ghiringhelli, F., Lançon, A., Populaire, C., Damette, A., Collonge-Rame, M.A., Meunier-Beillard, N., Lejeune, C., Albuisson, J., Faivre, L.

Volltext

558PThe combination of trifluridine/tipiracil and oxaliplatin induces immunogenic cell death in microsatellite stable colorectal cancer von Ghiringhelli, F, Limagne, E, Thibaudin, M, Nuttin, L, Spill, A, Derangere, V, Cattan, V, Peranzoni, E, Amellal, N

Volltext

PD-L1 dans les exosomes circulants de patients atteints de mélanome : un nouveau biomarqueur ? von Nardin, C., Cordonnier, M., Chanteloup, G., Derangere, V., Algros, M.-P., Marcion, G., Arnould, L., Garrido, C., Gobbo, J., Aubin, F.

Volltext

Suivi du taux de PD-L1 dans les exosomes pour évaluer la réponse tumorale dans le mélanome von Nardin, C., Cordonnier, M., Chanteloup, G., Derangere, V., Algros, M.-P., Marcion, G., Arnould, L., Garrido, C., Gobbo, J., Aubin, F.

Volltext

An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients: EP1.01-25 von Richard, C, Fumet, J, Chevrier, S, Derangere, V, Boidot, R, Truntzer, C, Ghiringhelli, F

Volltext

54P Phase I dose-escalation study of trifluridine/tipiracil plus XB2001 and bevacizumab in chemorefractory advanced colorectal cancer: The TASKIN study von Roussot, N., Thibaudin, M., Burlot, C., Schmitt, A., Hervieu, A., Bellio, H., Fraisse, C., Lagrange, A., Tharin, V.Z., Zanetta, S., Vincent, J., Bengrine Lefevre, L., Hennequin, A., Constantin, G., Rederstorff, E., Bertaut, A., Derangère, V., Truntzer, C., Fumet, J-D., Ghiringhelli, F.

Volltext